Compare NNNN & ALIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | ALIT |
|---|---|---|
| Founded | 2021 | 2017 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2025 | N/A |
| Metric | NNNN | ALIT |
|---|---|---|
| Price | $26.06 | $2.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.25 |
| AVG Volume (30 Days) | 26.9K | ★ 13.8M |
| Earning Date | 04-28-2026 | 11-05-2025 |
| Dividend Yield | N/A | ★ 7.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | $8,185,146.00 | ★ $2,289,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.56 |
| P/E Ratio | $534.57 | ★ N/A |
| Revenue Growth | ★ 21.95 | N/A |
| 52 Week Low | $5.18 | $1.89 |
| 52 Week High | $55.65 | $7.66 |
| Indicator | NNNN | ALIT |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 37.01 |
| Support Level | $26.89 | $2.00 |
| Resistance Level | $44.73 | $2.18 |
| Average True Range (ATR) | 5.72 | 0.11 |
| MACD | -0.32 | 0.02 |
| Stochastic Oscillator | 22.84 | 19.15 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.